Recommendations for the prevention of pregnancy-associated venous thromboembolism

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 52, Issue 1, 2012, Pages 3-13

  McLintock, Claire ^a   Brighton, Tim ^b   Chunilal, Sanjeev ^c,d   Dekker, Gus ^e,f   McDonnell, Nolan ^g   McRae, Simon ^h   Muller, Peter ^f   Tran, Huyen ^c,d,i   Walters, Barry N J ^j   Young, Laura ^a,k  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c MONASH MEDICAL CENTRE   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e UNIVERSITY OF ADELAIDE   (Australia)

^f WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^g UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^h ROYAL ADELAIDE HOSPITAL   (Australia)

ⁱ ALFRED HOSPITAL   (Australia)

^j KING EDWARD MEMORIAL HOSPITAL   (Australia)

^k UNIVERSITY OF AUCKLAND   (New Zealand)

more..

Author keywords

pregnancy; prevention; risk factors; thromboprophylaxis; venous thromboembolism

Indexed keywords

DALTEPARIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; TINZAPARIN; WARFARIN;

ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ANTITHROMBIN DEFICIENCY; AUSTRALIA AND NEW ZEALAND; CESAREAN SECTION; COMPRESSION GARMENT; CONSENSUS DEVELOPMENT; DRUG BIOAVAILABILITY; FAMILY HISTORY; FEMALE; GASTROCNEMIUS MUSCLE; HIGH RISK PREGNANCY; HUMAN; HYPEREMESIS GRAVIDARUM; IMMOBILIZATION; INFERTILITY THERAPY; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; MATERNAL MORBIDITY; MATERNAL MORTALITY; MATERNAL SMOKING; MULTIPLE PREGNANCY; MUSCLE EXCITATION; OBESITY; OBSTETRIC ANESTHESIA; PLACENTA DISORDER; POSTPARTUM HEMORRHAGE; PREECLAMPSIA; PREGNANCY DISORDER; PRENATAL PERIOD; PRIORITY JOURNAL; PUERPERAL INFECTION; PUERPERIUM; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK; SPINAL HEMATOMA; THROMBOPHILIA; THROMBOSIS PREVENTION; VARICOSIS; VENOUS THROMBOEMBOLISM;

AUSTRALIA; FEMALE; HUMANS; NEW ZEALAND; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PUERPERAL DISORDERS; RISK ASSESSMENT; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 84856970795     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2011.01357.x     Document Type: Review

References (71)

1. Cantwell R, Clutton-Brock T, Cooper G, et al., Saving Mothers' Lives: reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 2011; 118 (Suppl 1): 1-203.
2. Lewis GE,. The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving Mother's Lives: Reviewing Maternal Deaths to Make Motherhood Safer-2003-2005. The Seventh Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. London: CEMACH, 2007.
3. Tooher R, Gates S, Dowswell T, Davis L-J,. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Cochrane Database Syst Rev 2010; 5: CD001689.
4. National Health and Medical Research Council. Clinical Practice Guidelines for the Prevention of Venous Thromboembolism (Deep Vein Thrombosis and Pulmonary Embolism) in Patients Admitted to Australian Hospitals. Melbourne: National Health and Medical Research Council, 2009.
5. Heit JA, Kobbervig CE, James AH, et al., Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med 2005; 143: 697-706.
6. Pomp ER, Lenselink AM, Rosendaal FR, Doggen CJ,. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost 2008; 6: 632-637. (Pubitemid 351404930)
7. Rosendaal FR,. Risk factors for venous thrombotic disease. Thromb Haemost 1999; 82: 610-619.
8. Andersen BS, Steffensen FH, Sorensen HT, et al., The cumulative incidence of venous thromboembolism during pregnancy and puerperium-an 11 year Danish population-based study of 63,300 pregnancies. Acta Obstet Gynecol Scand 1998; 77: 170-173. (Pubitemid 28075384)
9. Gherman RB, Goodwin TM, Leung B, et al., Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy. Obstet Gynecol 1999; 94: 730-734. (Pubitemid 29484440)
10. Jacobsen AF, Skjeldestad FE, Sandset PM,. Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium-a register-based case-control study. Am J Obstet Gynecol 2008; 198: 233 e1-7.
11. James AH, Jamison MG, Brancazio LR, Myers ER,. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol 2006; 194: 1311-1315.
12. Lindqvist P, Dahlback B, Marsal K,. Thrombotic risk during pregnancy: a population study. Obstet Gynecol 1999; 94: 595-599. (Pubitemid 29460947)
13. McColl MD, Ramsay JE, Tait RC, et al., Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost 1997; 78: 1183-1188. (Pubitemid 27464583)
14. Blanco-Molina A, Trujillo-Santos J, Criado J, et al., Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry. Thromb Haemost 2007; 97: 186-190. (Pubitemid 46592137)
15. Sharma S, Monga D,. Venous thromboembolism during pregnancy and the post-partum period: incidence and risk factors in a large Victorian health service. Aust NZ J Obstet Gynaecol 2008; 48: 44-49. (Pubitemid 351239127)
16. Bodker B, Hvidman L, Weber T, et al., Maternal deaths in Denmark 2002-2006. Acta Obstet Gynecol Scand 2009; 88: 556-562.
17. Clark SL, Belfort MA, Dildy GA, et al., Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery. Am J Obstet Gynecol 2008; 199: 36.e1-36.e5. discussion 91-2 e7-11.
18. Samuelsson E, Hellgren M, Hogberg U,. Pregnancy-related deaths due to pulmonary embolism in Sweden. Acta Obstet Gynecol Scand 2007; 86: 435-443. (Pubitemid 46747702)
19. Sullivan EA, Hall B, King J,. Maternal Deaths in Australia 2003-2005. Maternal Deaths Series No. 3. Sydney: AIHW National Perinatal Statistics Unit, 2008.
20. Morris JM, Algert CS, Roberts CL,. Incidence and risk factors for pulmonary embolism in the postpartum period. J Thromb Haemost 2010; 8: 998-1003.
21. Rosfors S, Noren A, Hjertberg R, et al., A 16-year haemodynamic follow-up of women with pregnancy-related medically treated iliofemoral deep venous thrombosis. Eur J Vasc Endovasc Surg 2001; 22: 448-455. (Pubitemid 33085555)
22. Greer IA,. Thrombosis in pregnancy: maternal and fetal issues. Lancet 1999; 353: 1258-1265. (Pubitemid 29168473)
23. James AH,. Thromboembolism in pregnancy: recurrence risks, prevention and management. Curr Opin Obstet Gynecol 2008; 20: 550-556.
24. Macklon NS, Greer IA, Bowman AW,. An ultrasound study of gestational and postural changes in the deep venous system of the leg in pregnancy. Br J Obstet Gynaecol 1997; 104: 191-197. (Pubitemid 27065142)
25. Simpson EL, Lawrenson RA, Nightingale AL, Farmer RD,. Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database. BJOG 2001; 108: 56-60. (Pubitemid 32102604)
26. Chandra D, Parisini E, Mozaffarian D,. Meta-analysis: travel and risk for venous thromboembolism. Ann Intern Med 2009; 151: 180-190.
27. Brill-Edwards P, Ginsberg JS, Gent M, et al., Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in this Pregnancy Study Group. N Engl J Med 2000; 343: 1439-1444.
28. De Stefano V, Martinelli I, Rossi E, et al., The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis. Br J Haematol 2006; 135: 386-391. (Pubitemid 44484848)
29. Pabinger I, Grafenhofer H, Kaider A, et al., Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis. J Thromb Haemost 2005; 3: 949-954. (Pubitemid 41632825)
30. White RH, Chan WS, Zhou H, Ginsberg JS,. Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism. Thromb Haemost 2008; 100: 246-252.
31. Greer IA,. Prevention of venous thromboembolism in pregnancy. Best Pract Res Clin Haematol 2003; 16: 261-278.
32. Lim W, Crowther MA, Eikelboom JW,. Management of antiphospholipid antibody syndrome: a systematic review. JAMA 2006; 295: 1050-1057.
33. Robertson L, Wu O, Langhorne P, et al., Thrombophilia in pregnancy: a systematic review. Br J Haematol 2006; 132: 171-196. (Pubitemid 43381552)
34. Gerhardt A, Scharf RE, Zotz RB,. Effect of hemostatic risk factors on the individual probability of thrombosis during pregnancy and the puerperium. Thromb Haemost 2003; 90: 77-85. (Pubitemid 36873862)
35. Martinelli I, De Stefano V, Taioli E, et al., Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium. Thromb Haemost 2002; 87: 791-795. (Pubitemid 34516603)
36. Middeldorp S, van Hylckama Vlieg A,. Does thrombophilia testing help in the clinical management of patients? Br J Haematol 2008; 143: 321-335.
37. Middeldorp S, van der Meer J, Hamulyak K, Buller HR,. A rebuttal: counseling pregnant women with factor V Leiden homozygosity: use absolute instead of relative risks. Thromb Haemost 2002; 87: 360-361; author reply 1. (Pubitemid 34139889)
38. Grandone E, Margaglione M, Colaizzo D, et al., Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations. Am J Obstet Gynecol 1998; 179: 1324-1328. (Pubitemid 28533795)
39. McColl MD, Ellison J, Reid F, et al., Prothrombin 20210 G - >A, MTHFR C677T mutations in women with venous thromboembolism associated with pregnancy. BJOG 2000; 107: 565-569. (Pubitemid 30160552)
40. Meglic L, Stegnar M, Milanez T, et al., Factor V Leiden, prothrombin 20210G - > A, methylenetetrahydrofolate reductase 677C - > T and plasminogen activator inhibitor 4G/5G polymorphism in women with pregnancy-related venous thromboembolism. Eur J Obstet Gynecol Reprod Biol 2003; 111: 157-163. (Pubitemid 37338734)
41. Bank I, Libourel EJ, Middeldorp S, et al., Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study. Arch Intern Med 2004; 164: 1932-1937. (Pubitemid 39274365)
42. Couturaud F, Kearon C, Leroyer C, et al., Incidence of venous thromboembolism in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. Thromb Haemost 2006; 96: 744-749. (Pubitemid 44883814)
43. Folkeringa N, Brouwer JL, Korteweg FJ, et al., High risk of pregnancy-related venous thromboembolism in women with multiple thrombophilic defects. Br J Haematol 2007; 138: 110-116. (Pubitemid 46889789)
44. Friederich PW, Sanson BJ, Simioni P, et al., Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis. Ann Intern Med 1996; 125: 955-960. (Pubitemid 26424523)
45. Martinelli I, Legnani C, Bucciarelli P, et al., Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia. Thromb Haemost 2001; 86: 800-803. (Pubitemid 32834188)
46. Middeldorp S, Henkens CM, Koopman MM, et al., The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis. Ann Intern Med 1998; 128: 15-20. (Pubitemid 28016713)
47. Middeldorp S, Libourel EJ, Hamulyak K, et al., The risk of pregnancy-related venous thromboembolism in women who are homozygous for factor V Leiden. Br J Haematol 2001; 113: 553-555. (Pubitemid 32523169)
48. Pabinger I, Nemes L, Rintelen C, et al., Pregnancy-associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V Leiden. Hematol J 2000; 1: 37-41.
49. McLintock C, North RA, Dekker G,. Inherited thrombophilias for pregnancy-associated venous thromboembolism and obstetric complications. Curr Probl Obstet Gynecol Fertil 2001; 24: 114-149.
50. Weitz JI, Middeldorp S, Geerts W, Heit JA,. Thrombophilia and new anticoagulant drugs. Hematology Am Soc Hematol Educ Program 2004; 424-438.
51. Bezemer ID, van der Meer FJM, Eikenboom JCJ, et al., The value of family history as a risk indicator for venous thrombosis. Arch Intern Med 2009; 169: 610-615.
52. Nelson-Piercy C,. Guideline No. 37. Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. London: Royal College of Obstetricians and Gynaecologists, 2009.
53. Greer IA, Nelson-Piercy C,. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 2005; 106: 401-407. (Pubitemid 40981229)
54. Bates SM, Greer IA, Pabinger I, et al., Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 844S-886S. (Pubitemid 351892978)
55. Clark SL, Porter TF, West FG,. Coumarin derivatives and breast-feeding. Obstet Gynecol 2000; 95: 938-940.
56. Knight M,. Antenatal pulmonary embolism: risk factors, management and outcomes. BJOG 2008; 115: 453-461. (Pubitemid 351225139)
57. Geerts WH, Bergqvist D, Pineo GF, et al., Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 381S-453S. (Pubitemid 351894916)
58. Simioni P, Sanson B-J, Prandoni P, et al., Incidence of venous thromboembolism in families with inherited thrombophilia. Thromb Haemost 1999; 81: 198-202. (Pubitemid 29078302)
59. Vossen CY, Conard J, Fontcuberta J, et al., Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT). J Thromb Haemost 2005; 3: 459-464. (Pubitemid 41632870)
60. De Stefano V, Leone G, Mastrangelo S, et al., Thrombosis during pregnancy and surgery in patients with congenital deficiency of antithrombin III, protein C, protein S. Thromb Haemost 1994; 71: 799-800. (Pubitemid 24177974)
61. Vicente V, Rodriguez C, Soto I, et al., Risk of thrombosis during pregnancy and post-partum in hereditary thrombophilia. Am J Hematol 1994; 46: 151-152. (Pubitemid 24181630)
62. Loo CC, Dahlgren G, Irestedt L,. Neurological complications in obstetric regional anaesthesia. Int J Obstet Anesth 2000; 9: 99-124. (Pubitemid 30182229)
63. Kopp SL, Horlocker TT,. Anticoagulation in pregnancy and neuraxial blocks. Anesthesiol Clin 2008; 26: 1-22, v. (Pubitemid 351308162)
64. Hill D,. The use of remifentanil in obstetrics. Anesthesiol Clin 2008; 26: 169-182, viii. (Pubitemid 351305507)
65. Jacobsen AF, Skjeldestad FE, Sandset PM,. Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study. J Thromb Haemost 2008; 6: 905-912. (Pubitemid 351689910)
66. Larsen TB, Sorensen HT, Gislum M, Johnsen SP,. Maternal smoking, obesity, and risk of venous thromboembolism during pregnancy and the puerperium: a population-based nested case-control study. Thromb Res 2007; 120: 505-509. (Pubitemid 47094915)
67. Lindqvist PG, Torsson J, Almqvist A, Bjorgell O,. Postpartum thromboembolism: severe events might be preventable using a new risk score model. Vasc Health Risk Manag 2008; 4: 1081-1087.
68. Samama MM,. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med 2000; 160: 3415-3420.
69. Danilenko-Dixon DR, Heit JA, Silverstein MD, et al., Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or post partum: a population-based, case-control study. Am J Obstet Gynecol 2001; 184: 104-110. (Pubitemid 32141651)
70. Greer IA, Thomson AJ,. Thromboembolic disease in pregnancy and the puerperium. Green-top Guideline No. 28: Royal College of Obstetricians and Gynaecologists, 2007.
71. Chan WS,. The 'ART' of thrombosis: a review of arterial and venous thrombosis in assisted reproductive technology. Curr Opin Obstet Gynecol 2009; 21: 207-218.